- Research
- Open access
- Published:
Study on risk factors of preoperative deep vein thrombosis in patients with lower limb fractures and construction and validation of risk prediction nomogram model
BMC Surgery volumeĀ 24, ArticleĀ number:Ā 408 (2024)
Abstract
Background
To explore the correlation between the levels of D-dimer (D-D), fibrinogen (FIB), fibrinogen degradation products (FDP) and platelets (PLT) in peripheral blood of patients with lower limb fractures and the formation of deep vein thrombosis in lower limbs, and to establish a new thrombosis prediction model for patients with lower limb fractures.
Methods
The patients were divided into DVT group and non DVT group according to whether there was deep vein thrombosis of the lower extremity. The differences in the levels of D-D, FIB, FDP and platelets between the two groups were analyzed and compared. ROC curve was used to evaluate the levels of D-D, FIB, FDP and PLT in the peripheral blood of patients with lower extremity fracture to predict the formation of deep vein thrombosis of the lower extremity. Logistic regression analysis was used to analyze the related risk factors of deep vein thrombosis, and the corresponding nomogram risk prediction model of lower limb deep vein thrombosis in patients with lower limb fractures was drawn according to the regression coefficient, which was verified by calibration curve, receiver operating characteristic curve (ROC) and consistency index (C-index).
Results
The levels of D-D, FIB, FDP, and PLT in the DVT group were higher than those in the non DVT group, with statistical significance (Pā<ā0.05); Moreover, FIB is superior to D-D, FDP, and PLT in predicting the risk of fractures and thrombosis, while PLT has the weakest predictive power. Multivariate logistic analysis showed that platelet, D-D, FIB and FDP were independent risk factors for deep vein thrombosis in patients with lower limb fractures (Pā<ā0.05); Based on the independent risk factors mentioned above, the complex logistic regression formula was transformed into a visual column chart, and the consistency index (C-index) was 0.962 and 0.936, and the external verification C-index was 0.841. The calibration curve showed that the nomogram is in high agreement with the actual results. The AUC value of ROC curve indicated that the nomogram has high prediction value.
Conclusions
The levels of D-D, FIB, FDP and PLT in peripheral blood of patients with lower limb fracture and DVT were significantly increased. Early monitoring of D-D, FIB, FDP and PLT levels in patients with lower limb fracture can effectively screen for lower limb deep vein thrombosis.
Introduction
Deep vein thrombosis (DVT) of lower limbs is caused by a variety of reasons, which lead to changes in the coagulation mechanism of the body to promote thrombosis, and then lead to stenosis or occlusion of the vascular lumen, which is more likely to occur in lower limb blood vessels (including femoral vein and deep leg vein) [1, 2]. It has been reported that deep vein thrombosis is a common complication after traumatic fracture. Among hospitalized patients, the risk of deep vein thrombosis in trauma patients is 13 times higher than that in non trauma patients [3]. Considering that fractures can damage the vascular wall to make the blood in a hypercoagulable state, which is easy to lead to thrombosis [4]. If the patient is complicated with deep vein thrombosis, the fracture healing will be greatly affected; In addition, pulmonary embolism (PE) caused by lower limb deep vein thrombosis poses a pathogenic threat to the health of patients [5]. In addition, lower limb fractures, as one of the common types of fractures, account for one-third of fracture patients and are mostly concentrated in the elderly population. With the increasing aging of the population, the proportion of patients with lower limb fractures is showing an increasing trend [6]. Clinically, the early symptoms of lower limb deep vein thrombosis are lack of specificity, and the symptoms are relatively hidden. Only 10ā17% of DVT patients have obvious clinical symptoms (such as lower limb swelling, local deep tenderness, back flexion pain), which is easy to cause misdiagnosis and missed diagnosis. Therefore, early diagnosis and intervention for high-risk patients has important clinical significance [7, 8]. At present, the commonly used methods for diagnosis of deep vein thrombosis include imaging detection methods such as vascular color ultrasound and venography. Although these technologies have certain specificity and sensitivity, they cannot be used to predict the occurrence of DVT (the high price and complicated operation limit their application in clinical disease screening). Therefore, it is very important for clinical diagnosis and treatment of lower limb deep vein thrombosis to explore new and effective predictive indicators for early diagnosis.
According to reports, levels of D-dimer (D-D), fibrinogen (FIB), fibrinogen degradation products (FDP), and platelets (PLT) can reflect the hypercoagulable state of the blood to some extent [9, 10]. FIB, as a glycoprotein synthesized and secreted by hepatocytes, can induce secondary fibrinolysis hyperfunction by increasing the activity of plasmin, and then participate in the process of coagulation and hemostasis, which has a certain correlation with the occurrence of DVT; While D-D, as plasmin hydrolyzed cross-linked fibrinogen, can also be used as an indicator of body thrombosis. When there is thrombosis in the vascular lumen, its indicator can significantly rise [11]; FDP have a certain correlation with D-D, which can reflect the coagulation function of the patient's body and are recognized as biochemical indicators of thrombotic diseases in clinical practice; Platelets mainly participate in the body's coagulation process by promoting hemostasis and accelerating coagulation. This study retrospectively analyzed 145 patients with lower limb fractures admitted to the emergency department of our hospital, analyzed the correlation and predictive value of D-D, FIB, FDP and PLT with lower limb deep vein thrombosis, analyzed the risk factors of lower limb fractures complicated with lower limb deep vein thrombosis, and constructed a nomogram of the risk probability of lower limb deep vein thrombosis, in order to effectively guide clinical diagnosis and treatment.
Materials and methods
Data collection
Retrospective analysis of the clinical data of 145 patients with traumatic fractures of the lower limbs who visited the department of General Surgery of our hospital from September 2022 to March 2023, including 70 males and 75 females, aged 26 to 76Ā years, with an average age of 53.78ā±ā11.76Ā years. Upon admission, the patients were divided into DVT group and non DVT group according to whether there was deep vein thrombosis of lower limbs. Inclusion criteria: (1) All fracture patients were diagnosed in accordance with the clinical diagnostic criteria for limb fractures in the "Chinese Open Fracture Diagnosis and Treatment Guidelines (2019 Edition)" [12]; (2) All patients underwent lower limb venous ultrasound examination, and patients with lower limb thrombosis were diagnosed by completing lower limb angiography (DSA) if necessary; (3) The patient has no previous history of lower limb thrombosis. Exclusion criteria: (1) Previous history of pulmonary embolism; (2) Previous history of atrial fibrillation; (3) Patients who have undergone vascular related surgery in the past; (4) Patients with other organ tumors; (5) Patients with abnormal coagulation function. This study followed the ethical standards of Helsinki Declaration, and all patients were informed and signed the relevant consent before treatment.
Data collection
General and clinical data of all patients were collected, including gender, age, body mass index (BMI), trauma site, history of diabetes, history of hypertension, cause of injury, platelet, D-D, FIB and FDP levels. Compare the differences in D-D, FIB, FDP, and platelet levels between DVT and non DVT groups.
Diagnostic criteria of DVT
According to the "Guidelines for Diagnosis and Treatment of Deep Venous Thrombosis" [13]: (1) The lower limbs are swollen and painful; (2) The blood coagulation function is in hypercoagulable state; (3) D-D levelā>ā500 μg/L; (4) B-ultrasound examination can directly see that the blood vessels can not be squashed by the probe, and there is uneven echo shadow in the lumen; (5) The blood vessels can't be completely filled or appear defect after filling. During the examination, 1ā~ā4 items were screened first, and those whose first four items met the requirements were screened for the fifth item, and the diagnosis was DVT according to the results.
Therapeutic method
For each fracture patient upon admission, we immediately performed lower limb venous ultrasound to assist in the diagnosis, followed by selective interventions to prevent or treat lower limb deep vein thrombosis (DVT). For patients without thrombus, it is considered that fracture can make blood in hypercoagulable state by damaging blood vessel wall, which will easily lead to thrombosis and increase the risk of thrombosis, so low dose anticoagulation can be selected to prevent it, and the dose is 0.2Ā ml of low molecular weight heparin (2/ day); According to the "Guidelines for Prevention of Venous Thromboembolism in Orthopedic Surgery in China" [14], for patients with thrombus, they can be treated according to their weight. The routine dose is 0.6Ā ml of low molecular weight heparin (2/ day). Both patients stopped anticoagulation one day before operation and resumed anticoagulation treatment as soon as possible after operation. In addition, for patients with deep venous thrombosis of lower limbs, pneumatic pump can be used to contract the muscles of the ankle and calf after operation to promote local blood circulation. Improving the venous return of lower limbs can also play a therapeutic role to some extent.
Statistical analysis
SPSS (version 26.0) and R language (version 4.2.1) software was used for statistical analysis of the data. The counting data is represented by n (%), and inter group comparisons are performed using Ļ2 tests or Fisher tests (nā<ā5); The measurement data is expressed as meanā±āstandard deviation (xā±ās), and t-test is used for inter group comparison. The predictive value of using receiver operating characteristic curve (ROC curve) to evaluate D-D, FIB, FDP, and PLT levels in DVT patients with lower limb fractures. Logistic regression analysis was used to analyze the related risk factors of deep vein thrombosis. Multifactor Logistic regression was used to establish a prediction model for the risk of deep vein thrombosis of lower limbs. The model was visualized by nomogram, and the prediction accuracy and discrimination ability of the model were determined by calibration curve, ROC curve and consistency index (C index), αā=ā0.05 is the inspection level.
Results
Comparison of D-D, FIB, FDP, PLT levels between two groups
The levels of D-D, FIB, FDP, and PLT in the DVT group were higher than those in the non DVT group, with statistical significance (Pā<ā0.05), as shown in TableĀ 1.
Comparison of D-D, FIB, FDP, and PLT in predicting the risk of fracture combined with thrombosis
Draw ROC curves of D-D, FIB, FDP, and PLT to evaluate their ability to predict the risk of lower limb thrombosis. The results showed that the AUC of D-D, FIB, FDP, and PLT were 0.810 (95%CI: 0.725ā0.894, Pā<ā0.001), 0.861 (95%CI: 0.800ā0.923, Pā<ā0.001), 0.834 (95%CI: 0.755ā0.913, Pā<ā0.001), and 0.752 (95%CI: 0.670ā0.834, Pā<ā0.001), respectively. It can be seen that FIB is superior to D-D, FDP in predicting the risk of fracture complicated thrombosis PLT has the weakest predictive performance, as shown in Fig.Ā 1.
Single factor analysis of deep vein thrombosis in patients with lower limb fractures
This study included 145 patients with lower limb fractures, including 66 patients with lower limb deep vein thrombosis and 79 patients with non deep vein thrombosis. By comparing the differences of general information between the two groups, we found that BMI, trauma site, whether diabetes was combined with history, platelets, D-D, FIB and FDP were related to lower limb deep vein thrombosis (Pā<ā0.05), while gender, age The history of hypertension and the cause of injury were not related to the occurrence of deep vein thrombosis in the lower limbs (Pā>ā0.05), as shown in TableĀ 2.
Multifactor analysis of deep vein thrombosis in patients with lower limb fractures
Single factor meaningful indicators were included in the multivariate logistic regression model for analysis. The results showed that platelets (ORā=ā19.233, 95%CI: 2.890ā127.975, Pā=ā0.002), D-D (ORā=ā10.457, 95%CI: 1.492ā73.270, Pā=ā0.018), FIB (ORā=ā5.220, 95%CI: 1.315ā20.715, Pā=ā0.019), FDP (ORā=ā11.634, 95%CI: 1.710ā79.168, Pā=ā0.012) were independent risk factors for deep vein thrombosis in patients with lower limb fractures (Pā<ā0.05), as shown in TableĀ 3.
Construction of risk model for deep vein thrombosis in patients with lower limb fractures
We converted the complex logistic regression formula into a visual nomogram based on independent risk factors, with a C index of 0.962 (0.936ā0.988), suggesting that the nomogram has good discrimination and consistency, and the calibration curve shows that the risk probability of deep vein thrombosis of the lower extremity predicted by the nomogram model is consistent with the actual observation results in the study cohort (Ļ2ā=ā5.242, Pā=ā0.731), the AUC value of the ROC curve is 0.962, indicating that the predicted value of this column chart is high, as shown in Figs.Ā 2, 3, and 4.
Verification of nomogram prediction model
In the internal verification queue, the C index is 0.936 (0.894ā0.979) by bootstrapping validation analysis, which shows that the model has good discrimination. The calibration curve also performed well in the verification set, as shown in Figs.Ā 5 and 6. Similarly, we conducted external verification by collecting the relevant data of 93 patients with lower extremity fractures (including 44 patients with lower extremity deep vein thrombosis and 49 patients without lower extremity deep vein thrombosis) in the No.900th Hospital Cangshan branch from June 2023 to August 2024. The verification C index is 0.841 (0.761ā0.921), and the calibration curve also performed well in the verification set, as shown in Figs.Ā 7 and 8.
Discussion
Lower limb deep vein thrombosis is a kind of abnormal blood coagulation in the deep vein lumen, resulting in vascular stenosis or occlusion, which has been proved to be a common complication of lower limb fractures [1]. Considering that the pain at the fracture site in the early stage of trauma and local edema limit the movement of the patient's limbs, thereby slowing down the blood flow of the affected limb, coupled with the stress response caused by fractures, platelet adhesion may increase [15, 16]. Considering that deep vein thrombosis can bring bad prognosis to fracture patients and prolong the fracture healing time, in order to improve the quality of life of patients, it is clinically necessary to increase the assessment of early diagnosis and treatment of fracture patients with deep vein thrombosis risk [17]. However, in the past, a large number of studies have focused on exploring the prevention and treatment of thrombosis, and there have been relatively few studies related to the prediction of risk factors for lower limb thrombosis. At present, Doppler ultrasound (DUS) is a commonly used non-invasive examination method for deep vein thrombosis. Its positive rate for diagnosis of deep vein thrombosis of lower limbs can reach 95%, while its sensitivity for diagnosis of distal deep vein thrombosis is only 50%-70% [18]. Phlebography has high specificity and sensitivity, and when the clinical diagnosis of thrombosis by DUS is unclear, it can be diagnosed by phlebography [18]. However, due to its high price, complicated operation, invasive operation and other reasons, it is not conducive to the general survey of clinical diseases. At present, some researchers have proposed that the laboratory test results can be applied to the diagnosis of lower limb deep vein thrombosis to some extent, and confirmed that the levels of D-D and fibrinogen are at a high expression level in patients with deep venous thrombosis of lower limbs after fracture [19]. Pang et al. [20] also pointed out that PLT, D-D and FDP can be used as indicators to predict postoperative deep vein thrombosis in breast cancer patients, and the probability of postoperative deep vein thrombosis in breast cancer patients with high levels of PLT, D-D and FDP increased significantly. In this study, we divided the fracture patients into DVT group and non DVT group according to whether they were complicated with lower limb deep vein thrombosis at the time of admission. By comparing the levels of D-D, FIB, FDP and platelets between the two groups, we found that the levels of D-D, FIB, FDP and PLT in DVT group were higher than those in non DVT group, indicating that the levels of D-D, FIB, FDP and platelet were related to the occurrence of deep venous thrombosis in fracture patients. We used ROC curve to evaluate the levels of D-D, FIB, FDP and PLT in the peripheral blood of patients with lower limb fractures to predict lower limb deep vein thrombosis. The results showed that the four levels had a certain predictive value, and FIB was better than D-D, FDP and PLT in predicting the risk of fracture with thrombosis, while PLT had the weakest predictive effect.
In this study, we found that BMI, trauma site, whether diabetes was combined with history, platelets, D-D, FIB and FDP were related to the occurrence of deep venous thrombosis in lower limbs (Pā<ā0.05). However, the meaningful indicators of single factor were analyzed by multivariate Logistics regression model. The results showed that platelets, D-D, FIB and FDP were independent risk factors for deep venous thrombosis in patients with lower limb fractures (Pā<ā0.05). The analysis mainly includes the following reasons: (1) Fibrinolysis system is the key anticoagulant mechanism in the body, which can maintain the permeability Blood flow status and involvement in tissue repair [21]; As the degradation product of fibrin after plasmin is activated, D-D has strong antigenic specificity. Relevant research reports that its level increases with the activation of the fibrinolytic system [22], and its level change can be used to evaluate the balance between patients' coagulation and fibrinolytic systems, so it can be used as an important monitoring indicator of thrombotic diseases [23, 24]. (2) FIB, as a protein synthesized in the liver and involved in coagulation, belongs to a class of coagulation factors (coagulation factor I). It increases blood viscosity and peripheral resistance by promoting platelet aggregation, endothelial cell growth, proliferation, and enhancing smooth muscle contraction to accelerate thrombosis formation [25]. (3) FDP can reflect the activation of the fibrinolytic system and thrombosis of the body to a certain extent, and the FDP content is significantly higher than the normal value during primary fibrinolysis and venous thrombosis [26]. (4) PLT, as one of the common blood cells in the human body, are mainly involved in the hemostasis and coagulation processes of the body. People with higher levels of PLT in their peripheral blood are more likely to cause thrombosis than other populations (activated platelets can induce platelet aggregation by producing thromboxanes, leading to thrombosis) [10]. This study constructed a line chart risk prediction model based on independent risk factors (platelet, D-D, FIB, FDP) screened by logistic regression models. The predictive factors used in this model are common and easy to identify in clinical practice. The nomogram model shows strong predictive ability, good discrimination and consistency index (C-index) is 0.962 and 0.936, and the external verification C-index is 0.841, And during the validation process, the calibration curve showed that there was no significant difference (Pā>ā0.05) between the predicted risk probability of DVT using the column plot model and the actual observation results, indicating that the predictive model had a good fit. The AUC value of ROC curve indicated that the nomogram has high prediction value. Therefore, the nomogram prediction model is expected to be a useful tool to guide the anticoagulation treatment of patients with lower extremity fractures. Clinicians can effectively predict and screen patients with lower limb fractures complicated with DVT and formulate corresponding individualized prevention and treatment plans based on this model. For low-risk patients with DVT, we can temporarily stop anticoagulation treatment, closely observe the vital signs of patients and reduce unnecessary anticoagulation risks. For high-risk patients with DVT, we can take timely preventive and therapeutic measures (even before DUS results are available), and immediately start preventive anticoagulant therapy (such as low molecular weight heparin) and other supportive interventions (such as early activities, physical therapy, compression socks and the use of pneumatic compression devices, etc.), which may reduce the incidence of DVT and related complications (such as pulmonary embolism), thus improving the quality of life of patients. There are certain limitations to this study. The sample size included in this study is small and the time span is long. Some patients are excluded because of lack of data, so selection bias cannot be ruled out. In the future research, we will further expand the sample size in order to provide more accurate data support for clinic.
In summary, patients with lower limb fractures combined with DVT have significantly increased levels of D-D, FIB, FDP, and PLT in their peripheral blood, which is a good predictive indicator for lower limb fractures combined with DVT. In clinical practice, dynamic detection of peripheral blood D-D, FIB, FDP, and PLT levels can be used for early screening and diagnosis of patients with lower limb fractures to avoid affecting their poor prognosis. In addition, the column chart constructed based on this has high clinical application value, which can help clinical doctors formulate or adjust reasonable diagnosis and treatment plans in a timely manner.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Ohashi R, Sugimura M, Kawamura T, et al. Sensitivity to activated protein C in patients with deep vein thrombosis during early puerperium period. Acta Obstet Gynecol Scand. 2005;84(8):799ā801. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/j.0001-6349.2005.00762.x.
Cao Wenya is always red Padua score combined with serum D? Analysis of early prediction of deep vein thrombosis in patients with acute ischemic stroke by dimer. Nursing Research. 2019:33(16): 2841ā2844 https://doiorg.publicaciones.saludcastillayleon.es/10.12102/j.issn.1009-6493.2019.16.024.
Rogers FB, Cipolle MD, Velmahos G, et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma. 2002;53(1):142ā64. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/00005373-200207000-00032.
Meissner MH, Chandler WL, Elliott JS. Venous thromboembolism in trauma: a local manifestation of systemic hypercoagulability? J Trauma. 2003;54(2):224ā31. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/01.TA.0000046253.33495.70.
Gibson CJ, Alqunaibit D, Smith KE, et al. Probative value of the D-dimer assay for diagnosis of deep venous thrombosis in the coronavirus disease 2019 syndrome. Crit Care Med. 2020;48(12):e1322ā6. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/CCM.0000000000004614.
Beerekamp MSH, de Muinck Keizer RJO, Schep NWL, et al. Epidemiology of extremity fractures in the Netherlands. Injury. 2017;48(7):1355ā62. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.injury.2017.04.047. Epub 2017 Apr 24.
Zhenchao Gao, Mingxin Wang, Qiu Chen, et al. The significance of detection of Fib and D-dimer after lower limb fracture surgery and their predictive value in postoperative deep vein thrombosis. Pract Med Clin. 2018;21(12):1346ā9.
Cosmi B, Palareti G. āEarly thrombus removalā in iliac-femoral deep vein thrombosis for prevention of post-thrombotic syndrome. Ann Transl Med. 2019;7(Suppl 8):S343. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/atm.2019.09.102.
Chen S, Gao Y, Wang W, et al. Long-term clinical outcomes of complicated retrievable inferior vena cava filter for deep venous thrombosis patients: safety and effectiveness. Med Sci Monit. 2019;25:128ā34. https://doiorg.publicaciones.saludcastillayleon.es/10.12659/MSM.911813.
Napolitano M, Saccullo G, Marietta M, et al. Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus. Blood Transfus. 2019;17(3):171ā80. https://doiorg.publicaciones.saludcastillayleon.es/10.2450/2018.0143-18. Epub 2018 Oct 24.
Weizhi Chen, Yucong Yang. Application of thrombus related coagulation markers in the diagnosis of deep vein thrombosis. Psychol Monthly. 2019;14(20):179. https://doiorg.publicaciones.saludcastillayleon.es/10.19738/j.cnki.psy.2019.20.157.
Traumatic Orthopaedics Group, Orthopaedics Branch of Chinese Medical Association, External Fixation and Limb Reconstruction Group, Traumatic Infection Committee of Traumatic Surgeons Branch of Chinese Medical Association, et al. China Open Fracture Diagnosis and Treatment Guidelines (2019 Edition) [J]. Chin JĀ TraumaĀ Orthop. 2019;21(11):921ā8. https://doiorg.publicaciones.saludcastillayleon.es/10.3760/cma.j.issn.1671-7600.2019.11.001.
Department of Vascular Surgery, Surgery Branch of Chinese Medical Association. Guidelines for diagnosis and treatment of deep venous thrombosis (3rd Edition). Chin J General Surg. 2017;32(9):807ā12. https://doiorg.publicaciones.saludcastillayleon.es/10.3760/cma.j.issn.1007-631X.2017.09.032.
Osteology Branch of Chinese Medical Association. Guidelines for prevention of venous thromboembolism in orthopedic surgery in China. Chin J Orthopedics. 2016;2:65ā71. https://doiorg.publicaciones.saludcastillayleon.es/10.3760/cma.j.issn.0253-2352.2016.02.001.
Palareti G. D-dimer testing in patients with a first unprovoked venous thromboembolism. Ann Intern Med. 2015;162(9):670ā1. https://doiorg.publicaciones.saludcastillayleon.es/10.7326/L15-5089.
Tsantarliotou MP, Lavrentiadou SN, Psalla DA, et al. Suppression of plasminogen activator inhibitor-1 (PAI-1) activity by crocin ameliorates lipopolysaccharide-induced thrombosis in rats. Food Chem Toxicol. 2019;125:190ā7. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.fct.2019.01.001. Epub 2019 Jan 2.
Cao Z, Dong Y, Zeng J, et al. Whole-exome sequencing identified novel mutations in FGA and FGG genes in the patients with decreased fibrinogen. Thromb Res. 2019;177:79ā82. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.thromres.2019.03.002. Epub 2019 Mar 5.
Nyamekye IK. European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. J Med Vasc. 2022;47(2):53ā5. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jdmv.2022.04.003. Epub 2022 May 23.
Liang Xu, Fengying L. Ding Qian Changes and clinical significance of Caprini score, D-dimer and fibrinogen level in patients with deep venous thrombosis of lower limbs after fracture. J Clin Surg. 2019;27(4):328ā30. https://doiorg.publicaciones.saludcastillayleon.es/10.3969/j.issn.1005-6483.2019.04.018.
Pang M, Zhao F, Yu P, Zhang X, Xiao H, Qiang W, Zhu H, Zhao L. The significance of coagulation and fibrinolysis-related parameters in predicting postoperative venous thrombosis in patients with breast cancer. Gland Surg. 2021;10(4):1439ā46. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/gs-21-117.
Cai HX, Li XQ, Wang SF. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors. World J Gastroenterol. 2018;24(44):5046ā56. https://doiorg.publicaciones.saludcastillayleon.es/10.3748/wjg.v24.i44.5046.
Huebner BR, Moore EE, Moore HB, et al. Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium. J Surg Res. 2018;225:1ā5. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jss.2017.12.017. Epub 2018 Jan 5.
Qu SW, Cong YX, Wang PF, et al. Deep vein thrombosis in the uninjured lower extremity: a retrospective study of 1454 patients with lower extremity fractures. Clin Appl Thromb Hemost. 2021;27:1076029620986862. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/1076029620986862.
Xiaolin Z, Ying Z, Lin Ma. etc The application effect of D-dimer and ultrasound in evaluating the stability of lower limb deep vein thrombosis. Guangxi Med. 2018;40(23):2798ā801. https://doiorg.publicaciones.saludcastillayleon.es/10.11675/j.issn.0253-4304.2018.23.14.
Wilbur J, Shian B. Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy. Am Fam Physician. 2017;95(5):295ā302.
Hu Bo, Wang KE. Wang KE The significance of plasma D dimer and FDP detection in the diagnosis of DIC. Chongqing Med J. 2004;33(11):1666ā8.
Acknowledgements
The authors would like to thank all colleagues for data collection from the Department of General Surgery, No.900th Hospital of China People's Liberation Army Joint Logistics Support Force.
Clinical trial number
Not applicable.
Funding
This work was supported by the Natural Science Fund of Fujian Province (2017J01327); the Special Research Project of Training Injury Prevention and Treatment in the 900th Hospital of Joint Logistics Support Force (2023XL02), the Key Project of No.900th Hospital of Joint Logistics Support Force (2023ZS01).
Author information
Authors and Affiliations
Contributions
F Z: study design, data collection and manuscript writing. Xb C, Jq H: data collection and manuscript review. Xb C and C L: data collection and analysis
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
This study was conducted according to the ethical principles of medical research involving human subjects in theĀ Declaration of Helsinki and have been approved by the biomedical ethics committee of the 900th Hospital of Joint Logistics Support Force (Number: 2024ā093). Patients and their families signed informed consent before operation.
Written consent has been received from the subject.
Consent for publication
Written informed consent for publication was obtained from the participant.
Competing interests
The authors declare no competing interests.
Additional information
Publisherās Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the articleās Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleās Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zheng, F., Chen, X., Huang, J. et al. Study on risk factors of preoperative deep vein thrombosis in patients with lower limb fractures and construction and validation of risk prediction nomogram model. BMC Surg 24, 408 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12893-024-02718-3
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12893-024-02718-3